Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 108801-108850 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04193956
POINTING: Clinical Cohort Study of Patients With Melanoma and NSCLC Receiving Checkpoint Inhibitors
N/ARecruiting
3,500 participants
Started: Aug 1, 2018 · Completed: Sep 30, 2024
2 conditions1 sponsor2 locations
NCT04814355
The Effect of Celecoxib on Neuroinflammation in MDD
PHASE4Active, not recruiting
42 participants
Started: Aug 1, 2018 · Completed: Feb 28, 2026
2 conditions2 sponsors1 location
NCT03430401
Computer-based Cognitive Rehabilitation Program for Healthy Older Adults, Older People With Mild Cognitive Impairment and Mild Dementia
NAActive, not recruiting
60 participants
Started: Aug 1, 2018 · Completed: Dec 1, 2025
3 conditions1 sponsor1 location
NCT03571763
The Impact of Anti-thrombosis on Cerebral Microbleeds and Intracranial Hemorrhage in Ischemic Stroke Patients
N/ARecruiting
1,875 participants
Started: Aug 1, 2018 · Completed: Dec 30, 2026
1 condition1 sponsor1 location
NCT05292573
Longitudinal Follow-up in Women With Endometrial Hyperplasia Without Atypia
PHASE3Recruiting
1,000 participants
Started: Aug 1, 2018 · Completed: Jan 29, 2026
1 condition1 sponsor1 location
NCT03187535
Effect of TEAS on PONV After Spinal Surgery
NARecruiting
72 participants
Started: Aug 1, 2018 · Completed: Dec 20, 2026
1 condition1 sponsor1 location
NCT03535545
Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis Patients
PHASE1Recruiting
100 participants
Started: Aug 1, 2018 · Completed: Jun 30, 2026
2 conditions2 sponsors1 location
NCT03620578
DA-EPOCH-R Induction Followed by Nivolumab Consolidation in Newly Diagnosed MYC, BCL2 and/or BCL6 Rearranged HGBL
PHASE2Active, not recruiting
97 participants
Started: Aug 1, 2018 · Completed: Oct 31, 2026
5 conditions1 sponsor24 locations
NCT03647072
PPI Versus Histamine Antagnists as Adjuvant to Chemotherapy
PHASE3Recruiting
60 participants
Started: Aug 1, 2018 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT03502408
Perfusion Imaging Evaluation for Ischemic Stroke on 6-24 Hours Undergoing Endovascular Thrombectomy
NARecruiting
55 participants
Started: Aug 1, 2018 · Completed: Aug 1, 2026
1 condition1 sponsor1 location
NCT03647098
Survival Outcomes of Lung Cancer
N/ARecruiting
20,000 participants
Started: Aug 1, 2018 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT03646968
Study of Anlotinib Combined With Docetaxel in Non-Driver Mutation Non-squamous NSCLC: the Save Study
PHASE2Recruiting
43 participants
Started: Aug 1, 2018 · Completed: Jun 1, 2025
1 condition1 sponsor1 location
NCT06690983
Tau PET/CT in Various Tau-Related Disease Patients
N/ARecruiting
500 participants
Started: Aug 1, 2018 · Completed: Dec 1, 2027
3 conditions2 sponsors2 locations
NCT06400550
Identification of Metabolic Phenotypes Associated With Melanoma Metastasis
N/ARecruiting
400 participants
Started: Aug 1, 2018 · Completed: Aug 1, 2028
1 condition1 sponsor1 location
NCT03550885
Diet Modulation of Bacterial Sulfur and Bile Acid Metabolism and Colon Cancer Risk
NAEnrolling by invitation
44 participants
Started: Aug 1, 2018 · Completed: Dec 15, 2025
1 condition3 sponsors1 location
NCT04041154
Behavioral and Neural Representations of Subjective Effort Cost
NARecruiting
185 participants
Started: Aug 1, 2018 · Completed: Dec 31, 2029
1 condition2 sponsors1 location
NCT03418350
The Role of Laryngopharyngeal Reflux in IPF
N/ARecruiting
60 participants
Started: Aug 1, 2018 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05404061
The Poor Responders Study
NARecruiting
220 participants
Started: Aug 1, 2018 · Completed: Sep 1, 2027
3 conditions1 sponsor1 location
NCT06361524
Gut Microbiome Profiling in Patients With Chronic Heart Failure
N/AEnrolling by invitation
150 participants
Started: Aug 1, 2018 · Completed: Dec 31, 2028
2 conditions3 sponsors1 location
NCT03556709
Walking Ankle Robot for Foot Drop in Aging and Disabled Populations: A Demonstration Project
NANot yet recruiting
100 participants
Started: Aug 1, 2018 · Completed: Dec 31, 2028
4 conditions1 sponsor0 locations
NCT03563131
Tibial and Femoral Components Migration and Adaptive Bone Remodeling After Insertion of Persona® TKA
NAActive, not recruiting
66 participants
Started: Aug 1, 2018 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT03745534
Cochlear Implantation After Gamma Knife Radiosurgery with EABR and Correlation to Postoperative Hearing Results - a Pilot Study
N/ARecruiting
8 participants
Started: Aug 1, 2018 · Completed: Oct 30, 2026
2 conditions1 sponsor1 location
NCT03626103
Intervention to Prevent Peer Violence & Depressive Symptoms Among At-Risk Adolescents
NAActive, not recruiting
800 participants
Started: Aug 1, 2018 · Completed: Feb 28, 2025
2 conditions2 sponsors2 locations
NCT03655249
Effects of AD on VI in Patients With CF
NARecruiting
30 participants
Started: Aug 1, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03646396
Effect of Sofosbuvir-daclatasuvir on Angiogenesis
NARecruiting
40 participants
Started: Aug 1, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03924830
Influence of Surface Sealants on the Quality of Posterior Restorations With Bulk Fill Composites
NAActive, not recruiting
53 participants
Started: Aug 1, 2018 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT03478826
Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)
N/ARecruiting
635 participants
Started: Aug 1, 2018 · Completed: Jan 31, 2028
1 condition1 sponsor1 location
NCT03604302
Evaluation of Preoperative Functional Magnetic Resonance Imaging (fMRI) in Patients With Brain Tumors
NAActive, not recruiting
33 participants
Started: Aug 1, 2018 · Completed: Jul 31, 2026
1 condition2 sponsors1 location
NCT03410498
The Effects of FES in a Variety of Walking Conditions in People With MS
NARecruiting
20 participants
Started: Aug 1, 2018 · Completed: Dec 29, 2024
1 condition1 sponsor1 location
NCT04348253
Danish Multicenter Scapholunate Ligament Study
NARecruiting
100 participants
Started: Aug 1, 2018 · Completed: Apr 30, 2033
2 conditions1 sponsor2 locations
NCT04507997
Angelman Syndrome Natural History Study
N/ARecruiting
300 participants
Started: Aug 1, 2018 · Completed: Apr 30, 2031
1 condition8 sponsors11 locations
NCT03041610
Pedometer-Based Walking Intervention in Patients With Chronic Heart Failure With Reduced Ejection Fraction
NAActive, not recruiting
202 participants
Started: Aug 1, 2018 · Completed: Dec 30, 2023
1 condition6 sponsors1 location
NCT04287465
Comparison of Outcomes in Asleep and Awake DBS With a Directional Electrode
N/AActive, not recruiting
30 participants
Started: Aug 1, 2018 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT03663777
Handgrip Training in Patients With Peripheral Artery Disease
NARecruiting
30 participants
Started: Aug 1, 2018 · Completed: Dec 30, 2025
1 condition2 sponsors2 locations
NCT03862365
Exploring the Genetics of Neuropathic Pain
N/ARecruiting
5,000 participants
Started: Aug 1, 2018 · Completed: Dec 31, 2027
3 conditions8 sponsors5 locations
NCT04303403
Study of Trametinib and Ruxolitinib in Colorectal Cancer and Pancreatic Adenocarcinoma
PHASE1Recruiting
48 participants
Started: Jul 31, 2018 · Completed: Mar 31, 2024
2 conditions1 sponsor1 location
NCT03638375
TIL and Anti-PD1 in Metastatic Melanoma
PHASE1/PHASE2Active, not recruiting
34 participants
Started: Jul 31, 2018 · Completed: Nov 29, 2025
3 conditions2 sponsors1 location
NCT03540420
Atezolizumab After Concurrent Chemo-radiotherapy Versus Chemo-radiotherapy Alone in Limited Disease Small-cell Lung Cancer
PHASE2Active, not recruiting
212 participants
Started: Jul 31, 2018 · Completed: Apr 1, 2027
1 condition45 sponsors41 locations
NCT03523416
Early Feasibility Study - Edwards APTURE Transcatheter Shunt System
NAActive, not recruiting
71 participants
Started: Jul 31, 2018 · Completed: Nov 30, 2028
1 condition1 sponsor15 locations
NCT03173664
Post-Approval Study With the KAMRA Inlay
N/ANot yet recruiting
529 participants
Started: Jul 31, 2018 · Completed: Jan 31, 2026
1 condition1 sponsor0 locations
NCT03638999
NSAIDs Stent Study
EARLY_PHASE1Recruiting
36 participants
Started: Jul 31, 2018 · Completed: Oct 31, 2026
2 conditions1 sponsor1 location
NCT03927768
Abbreviated Breast MRI (AB-MRI) With Golden-angle Radial Compressed-sensing and Parallel Imaging (GRASP)
N/AActive, not recruiting
264 participants
Started: Jul 31, 2018 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT03372733
Dietary Omega-7 Palmitoleic Acid-Rich Oil on Lipoprotein Metabolism and Satiety in Adults
PHASE2Recruiting
110 participants
Started: Jul 31, 2018 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT03599765
Systemic Therapy With or Without Local Consolidative Therapy in Treating Patients With Oligometastatic Solid Tumor
PHASE2Active, not recruiting
380 participants
Started: Jul 31, 2018 · Completed: Dec 31, 2025
1 condition2 sponsors12 locations
NCT03431935
Predictors and Outcomes in Patients With Sickle Cell Disease
N/AActive, not recruiting
94 participants
Started: Jul 31, 2018 · Completed: Jan 31, 2026
1 condition4 sponsors2 locations
NCT03625011
Gabapentin Premedication to Reduce Postoperative Pain for Pediatric Tonsillectomy
PHASE4Recruiting
50 participants
Started: Jul 31, 2018 · Completed: Dec 31, 2019
2 conditions1 sponsor1 location
NCT02454907
The Use of Technology to Improve MS Clinical Trials and Patient Care
NAActive, not recruiting
150 participants
Started: Jul 31, 2018 · Completed: Oct 31, 2025
1 condition2 sponsors1 location
NCT03356132
An Analysis of Adverse Events and Satisfaction Outcomes of Women Who Underwent Primary and Secondary Breast Augmentation Using Silimed® Breast Implants
N/ARecruiting
632 participants
Started: Jul 31, 2018 · Completed: Dec 31, 2035
3 conditions1 sponsor1 location
NCT03630211
Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
PHASE2Recruiting
8 participants
Started: Jul 31, 2018 · Completed: Aug 1, 2026
4 conditions1 sponsor3 locations
NCT03433469
Osimertinib in Treating Participants With Stage I-IIIA EGFR-mutant Non-small Cell Lung Cancer Before Surgery
PHASE2Active, not recruiting
27 participants
Started: Jul 31, 2018 · Completed: Oct 31, 2026
7 conditions2 sponsors3 locations